Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy

Neurology

Volumn 70, Issue 18, 2008, Pages 1586-1593

  Pack, A M ^a,c   Morrell, M J ^b   Randall, A ^a   McMahon, D J ^a   Shane, E ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PARATHYROID HORMONE; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM INTAKE; CONTROLLED STUDY; EPILEPSY; FEMALE; FEMUR NECK; HUMAN; HYPERPARATHYROIDISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MINERAL METABOLISM; MONOTHERAPY; NUTRITIONAL STATUS; OSTEOLYSIS; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION;

EID: 42949119766     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000310981.44676.de     Document Type: Article

References (25)

1. PC Souverein DJ Webb H Petri J Weil TP Van Staa T Egberts Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database Epilepsia 46 2005 304 310
2. A Verrotti R Greco G Morgese F Chiarelli Increased turnover in epileptic patients treated with carbamazepine Epilepsia 47 2000 353 358
3. A Verrotti R Greco G Latini G Morgese F Chiarelli Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine Epilepsia 43 2002 1488 1492
4. H Tekgul G Dizdarer N Demir C Ozturk S Tutuncuoglu Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy J Child Neurol 19 2004 26 30
5. S Wu A Legido F DeLuca Effects of valproic acid on longitudinal bone growth J Child Neurol 19 2004 26 30
6. AM Pack MJ Morrell R Marcus Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy Ann Neurol 57 2005 252 257
7. PD Delmas R Eastell P Garnero The use of biochemical markers of bone turnover in osteoporosis Osteoporosis Int 11 suppl 6 2000 S2 S17
8. G Block AM Hartman CM Dresser MD Carroll J Gannon L Gardner A data-based approach to diet questionnaire design and testing Am J Epidemiol 124 1986 453 469
9. DK Katzman LK Bachrach DR Carter R Marcus Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls J Clin Endocrinol Metab 73 1991 1332 1339
10. BH Margolin Test for trend in proportions NL Johnson Encyclopedia of Statistical Sciences 1988 John Wiley & Sons New York 334 336
11. KE Bainbridge M Sowers X Lin SD Harlow Natural history of bone loss over 6 years among premenopausal and early postmenopausal women Am J Epidemiol 156 2002 410 417
12. MR Sowers JS Finkelstein B Ettinger The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN Osteoporos Int 14 2003 44 52
13. MR Sowers GA Greendale I Bondarenko Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN Osteoporos Int 14 2003 191 197
14. JA Kanis F Borgstrom C De Laet Assessment of fracture risk Osteoporos Int 16 2005 581 589
15. KE Ensrud TS Walczak T Blackwell ER Ensrud PJ Bowman KL Stone Antiepileptic drug use increases rates of bone loss in older women: a prospective study Neurology 62 2004 2051 2057
16. M Sowers M Crutchfield R Bandekar Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study J Miner Res 13 1998 1134 1140
17. J Tjellesen L Nilas C Christiansen Does carbamazepine cause disturbances in calcium metabolism in epileptic patients Acta Neurol Scand 68 1983 13 19
18. MJ Valimaki M Tiihonen K Laitinen Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs J Bone Miner Res 9 1994 631 637
19. S Bramswig A Zitterman HK Berthold Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults Calcif Tissue Int 73 2003 356 360
20. O Nakade DJ Baylink KH Lau Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro J Dent Res 74 1995 331 337
21. A Takahashi K Onodera H Shinoda Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria Jpn J Pharmacol 82 2000 82 84
22. TJ Hahn CR Scharp CA Richardson Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro J Clin Invest 62 1978 406 414
23. J Feldkamp A Becker OW Witte Long-term anticonvulsant therapy leads to low bone mineral density: evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells Exp Clin Endocrinol Diabetes 108 2000 37 43
24. M von Burstel Smith K Crofoot R Rodriguez-Proteau Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells Toxicol In Vitro 21 2007 855 862
25. JM Auszmann AT Vernillo AS Fine The effect of phenytoin on parathyroid hormone simulated cAMP activity in cultured murine osteoblasts Life Sci 46 1990 351 357